Thursday, June 1, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Assistant Professor of Pharmacy
Mayo Clinic College of Medicine
Director of Pharmacy
Minnesota Oncology
St. Paul, Minnesota
Clinical Pharmacy Manager
Division of Hematologic Malignancies and Cellular Therapies
Oncology Pharmacy Residency Program Director
The University of Kansas Cancer Center
Westwood, Kansas
Adjunct Clinical Assistant Professor
Clinical Pharmacist Practitioner
Transplant and Cellular Therapy
University of Nebraska Medical Center
Omaha, Nebraska
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Pharmacists - 0.50 Knowledge-based ACPE (0.050 CEUs)
This activity is intended for oncology pharmacists.
The goal of this activity is for learners to be better able to evaluate multiple myeloma (MM) therapies, mitigate drug-drug interactions and treatment side effects, and counsel patients as part of the interprofessional care team.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Assistant Professor of Pharmacy
Mayo Clinic College of Medicine
Director of Pharmacy
Minnesota Oncology
St. Paul, Minnesota
Clinical Pharmacy Manager
Division of Hematologic Malignancies and Cellular Therapies
Oncology Pharmacy Residency Program Director
The University of Kansas Cancer Center
Westwood, Kansas
Adjunct Clinical Assistant Professor
Clinical Pharmacist Practitioner
Transplant and Cellular Therapy
University of Nebraska Medical Center
Omaha, Nebraska
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Medscape designates this continuing education activity for 0.50 contact hour(s) (0.050 CEUs) (Universal Activity Number: JA0007105-0000-23-183-H01-P).
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CE Released: 5/25/2023
Valid for credit through: 5/25/2024
processing....
Please answer these questions to complement your learning experience.
